RefBan

Referral Banners

Yashi

Monday, February 17, 2014

Reuters Health Report

Click to View in Browser
02/17/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Effects of bullying may add up in kids: study
NEW YORK (Reuters Health) - The negative physical and mental effects tied to bullying among children and teens may accumulate throughout the years, according to a new study.
FDA rejects wider use of Xarelto drug
NEW YORK (Reuters) - U.S. health regulators have again declined to approve proposed wider uses of Bayer AG and Johnson & Johnson's lucrative blood clot preventer Xarelto, the drugmakers said on Friday.
Novartis to buy U.S.-based biotech CoStim for undisclosed price
ZURICH (Reuters) - Novartis said it will buy U.S.-based CoStim Pharmaceuticals Inc., a privately held biotechnology company focused on harnessing the immune system to eliminate immune-blocking signals from cancer, for an undisclosed price.
Number of test-tube babies born in U.S. hits record percentage
NEW YORK (Reuters) - More test-tube babies were born in the United States in 2012 than ever before, and they constituted a higher percentage of total births than at any time since the technology was introduced in the 1980s, according to a report released on Monday.
FDA warns about Medisca's L-citrulline supplement
WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Saturday certain lots of the supplement L-citrulline, used to treat genetic disorders found mostly in children, sold by compounding firm Medisca Inc were found to contain none of the drug, and warned doctors and patients not to use it.
Educating young men could expand 'morning after pill' use
NEW YORK (Reuters Health) - Young men know even less about emergency contraception than young women do, which may be limiting access to an effective means of preventing unwanted pregnancies, researchers say.
Aveo, Astellas end pact to develop cancer drug tivozanib
(Reuters) - Aveo Oncology and Astellas Pharma Inc said they would end an agreement to develop Aveo's lead experimental drug that has seen a string of failures in multiple cancer indications.
Digital media could work as tool to improve health
NEW YORK (Reuters Health) - After a desperate mother in South Wales, UK, posted a video of her baby having a seizure on Facebook, one of her friends provided the diagnosis that had eluded the boy's doctor.
Value of ice water soak for sore muscles still unclear
NEW YORK (Reuters Health) - The pain of a short soak in ice water is supposed to cure the longer-lasting discomfort of sore muscles, but researchers say it may not make enough difference to be worthwhile.
Matchmakers can get a happiness boost, too
NEW YORK (Reuters Health) - Fixing up your single friends this Valentine's Day might pay off for them, and it could make you happier too, according to a new group of studies.
Related Video
Nigeria harnesses the power of waste
Long-lived winter storm pelts northeast
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika